Insulet (NASDAQ: PODD), headquartered in Massachusetts, is an innovativemedical device company dedicated to making the lives of people with diabetesand other conditions easier through the use of its Omnipod® System productplatform. The Omnipod® System provides an alternative to traditional insulindelivery methods. With its simple, wearable design, the disposable Podprovides up to three days of non-stop insulin delivery, without the need to seeor handle a needle. Insulet also leverages the unique design of its Pod, bytailoring its Omnipod® System technology platform for the delivery of non-insulinsubcutaneous drugs across multiple therapeutic areas. Founded in2000, many users across the globe rely on Insulet's Omnipod® System tobring simplicity and freedom to their lives. For more information, please visit:www.insulet.com, www.myomnipod.com